GSK and Bio-Rad Laboratories are medical companies that are currently competing for investment.
1 report, 1 independent
Updated Jun 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GSK and Bio-Rad Laboratories are medical companies that are currently competing for investment.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GSK
British multinational pharmaceutical and biotechnology company
-
Bio-Rad Laboratories
American life science research firm
- Strategic acquisitions and product launches are driving growth for Bio-Rad Laboratories in the life science ddPCR and clinical diagnostics markets.
- Bio-Rad Laboratories is applying digital PCR technology through current partnerships, including Biodesix, Gencove, Insight Molecular, and Stilla Technologies.
Related events
- GSK and PainReform Ltd. are identified as competing healthcare companies for investment.
- GSK and Evolus are identified as competing healthcare companies in the market.
- GSK and Amgen are major biopharma players.
- GSK and Novartis are identified as major pharmaceutical companies.
- AbbVie, AstraZeneca, and GSK are major players in global drug development, facing challenges in the drug class and pursuing licensing deals with Chinese biotechs.